Cyrus Biotechnology Funding & Investors
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
https://cyrusbio.com/Total Amount Raised: $42,792,168
Cyrus Biotechnology Funding Rounds
Series B
$18,000,000
Series B Investors
W FundTrinity VenturesAgent CapitalYard VenturesiSelect FundOrbiMedWashington Research FoundationSelecta BiosciencesSeries B
$18,000,000
Series B Investors
W FundTrinity VenturesAgent CapitalYard VenturesiSelect FundOrbiMedWashington Research FoundationSelecta BiosciencesSeries A
$15,942,168
Series A Investors
Alumni Ventures GroupAlexandria Venture InvestmentsSeries A
$8,000,000
Series A Investors
Trinity VenturesOrbiMedSpringRock VenturesW FundSeries A
$15,942,168
Series A Investors
Alumni Ventures GroupAlexandria Venture InvestmentsSeries A
$8,000,000
Series A Investors
Trinity VenturesOrbiMedSpringRock VenturesW FundSeed
$850,000
Seed Investors
WINGSW FundSeed
$850,000
Seed Investors
WINGSW Fund
Funding info provided by Diffbot.